✦ LIBER ✦

Canagliflozin: SGLT2 inhibitor for treating type 2 diabetes

✍ Scribed by Donnelly, Richard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Canagliflozin, a Novel SGLT2 Inhibitor f

✍ Nigro, S. C.; Riche, D. M.; Pheng, M.; Baker, W. L. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 365 KB

SGLT2 versus DPP4 inhibitors for type 2

✍ Scheen, André J 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 53 KB

Dapagliflozin, an SGLT2 inhibitor, for d

✍ Markolf Hanefeld; Thomas Forst 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 90 KB

SGLT2 inhibitors race to enter type-2 di

✍ Sheridan, Cormac 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 333 KB

Clinical implication of SGLT2 inhibitors

✍ Kim, Go Woon; Chung, Sung Hyun 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 629 KB

Evaluating SGLT2 inhibitors for type 2 d

✍ Scheen, André J 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 427 KB